Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Combinatorial use of bone morphogenetic protein 6, noggin and SOST significantly predicts cancer progression.

Yuen HF, McCrudden CM, Grills C, Zhang SD, Huang YH, Chan KK, Chan YP, Wong ML, Law S, Srivastava G, Fennell DA, Dickson G, El-Tanani M, Chan KW.

Cancer Sci. 2012 Jun;103(6):1145-54. doi: 10.1111/j.1349-7006.2012.02252.x. Epub 2012 Apr 3.

2.

The prognostic significance of BMP-6 signaling in prostate cancer.

Yuen HF, Chan YP, Cheung WL, Wong YC, Wang X, Chan KW.

Mod Pathol. 2008 Dec;21(12):1436-43. doi: 10.1038/modpathol.2008.94. Epub 2008 Oct 17.

3.

Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.

Haudenschild DR, Palmer SM, Moseley TA, You Z, Reddi AH.

Cancer Res. 2004 Nov 15;64(22):8276-84.

4.

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

Feeley BT, Gamradt SC, Hsu WK, Liu N, Krenek L, Robbins P, Huard J, Lieberman JR.

J Bone Miner Res. 2005 Dec;20(12):2189-99. Epub 2005 Aug 1.

5.

Unique regulation of SOST, the sclerosteosis gene, by BMPs and steroid hormones in human osteoblasts.

Sutherland MK, Geoghegan JC, Yu C, Winkler DG, Latham JA.

Bone. 2004 Aug;35(2):448-54.

PMID:
15268896
6.

RNA interference for noggin enhances the biological activity of bone morphogenetic proteins in vivo and in vitro.

Takayama K, Suzuki A, Manaka T, Taguchi S, Hashimoto Y, Imai Y, Wakitani S, Takaoka K.

J Bone Miner Metab. 2009;27(4):402-11. doi: 10.1007/s00774-009-0054-x. Epub 2009 Feb 28.

PMID:
19252814
7.

Endogenous bone morphogenetic protein-7 controls the motility of prostate cancer cells through regulation of bone morphogenetic protein antagonists.

Ye L, Lewis-Russell JM, Kynaston H, Jiang WG.

J Urol. 2007 Sep;178(3 Pt 1):1086-91. Epub 2007 Jul 20.

PMID:
17644136
8.

BMP signaling pathways affect differently migration and invasion of esophageal squamous cancer cells.

Hu M, Cui F, Liu F, Wang J, Wei X, Li Y.

Int J Oncol. 2017 Jan;50(1):193-202. doi: 10.3892/ijo.2016.3802. Epub 2016 Dec 12.

PMID:
27959431
10.

Expression, regulation and clinical significance of bone morphogenetic protein 6 in esophageal squamous-cell carcinoma.

Raida M, Sarbia M, Clement JH, Adam S, Gabbert HE, Höffken K.

Int J Cancer. 1999 Sep 24;83(1):38-44.

11.

Promoter methylation of the bone morphogenetic protein 6 gene in multiple myeloma.

Hashida Y, Nemoto Y, Imajoh M, Murakami M, Taniguchi A, Komatsu N, Yokoyama A, Daibata M.

Oncol Rep. 2012 Mar;27(3):825-30. doi: 10.3892/or.2011.1548. Epub 2011 Nov 11.

PMID:
22086350
12.

Exploration of Shh and BMP paracrine signaling in a prostate cancer xenograft.

Shaw A, Gipp J, Bushman W.

Differentiation. 2010 Jan;79(1):41-7. doi: 10.1016/j.diff.2009.08.009. Epub 2009 Sep 20.

13.

Temporal and spatial expression profiles of BMP receptors and noggin during BMP-2-induced ectopic bone formation.

Nakamura Y, Wakitani S, Nakayama J, Wakabayashi S, Horiuchi H, Takaoka K.

J Bone Miner Res. 2003 Oct;18(10):1854-62.

14.

BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells.

Maegdefrau U, Bosserhoff AK.

Exp Mol Pathol. 2012 Feb;92(1):74-81. doi: 10.1016/j.yexmp.2011.10.004. Epub 2011 Oct 15.

PMID:
22024355
15.

Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.

Ohyama Y, Nifuji A, Maeda Y, Amagasa T, Noda M.

Endocrinology. 2004 Oct;145(10):4685-92. Epub 2004 Jun 24.

PMID:
15217980
16.

Bone morphogenetic protein 6 (BMP6) and BMP7 inhibit estrogen-induced proliferation of breast cancer cells by suppressing p38 mitogen-activated protein kinase activation.

Takahashi M, Otsuka F, Miyoshi T, Otani H, Goto J, Yamashita M, Ogura T, Makino H, Doihara H.

J Endocrinol. 2008 Dec;199(3):445-55. doi: 10.1677/JOE-08-0226. Epub 2008 Sep 9.

17.

Connective tissue growth factor gene expression alters tumor progression in esophageal cancer.

Koliopanos A, Friess H, di Mola FF, Tang WH, Kubulus D, Brigstock D, Zimmermann A, Büchler MW.

World J Surg. 2002 Apr;26(4):420-7. Epub 2002 Feb 4.

PMID:
11910473
18.

Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.

Feeley BT, Krenek L, Liu N, Hsu WK, Gamradt SC, Schwarz EM, Huard J, Lieberman JR.

Bone. 2006 Feb;38(2):154-66. Epub 2005 Aug 26.

PMID:
16126463
19.

The role of noggin in human mesenchymal stem cell differentiation.

Rifas L.

J Cell Biochem. 2007 Mar 1;100(4):824-34.

PMID:
17133353
20.

Downregulation of BMP6 enhances cell proliferation and chemoresistance via activation of the ERK signaling pathway in breast cancer.

Lian WJ, Liu G, Liu YJ, Zhao ZW, Yi T, Zhou HY.

Oncol Rep. 2013 Jul;30(1):193-200. doi: 10.3892/or.2013.2462. Epub 2013 May 14.

PMID:
23674072

Supplemental Content

Support Center